Anheuser-Busch Carbs Up

Recs

0

The year 2003 didn't go exactly as planned for Anheuser-Busch (NYSE: BUD), but the company's brand and reach still powered it to record earnings.

The world's largest brewer saw fourth-quarter profits grow 12.5% to $0.36 per share as revenue edged up 3.5%. It was the 21st consecutive quarter of double-digit EPS growth -- quite impressive considering the recent bear market. The company earned $2.48 per share for the full year on revenue of $16.3 billion. That's 12.7% and 4% higher, respectively, than 2002.

Things could have been better, however. The Atkins diet-fueled low-carbohydrate craze hurt Bud Light's growth and benefited rival Miller Lite, which has half the carbs. Bud Light, the best-selling beer in the U.S., still grew sales, but results were below expectations.

On the bright side, management showed off its skills by rolling out the low-carb Michelob Ultra, which CEO Patrick Stokes called "an outstanding success in 2003 at the super-premium price point." After exceeding all expectations, we'll probably see greater marketing support for this brand in 2004.

Another sharp move is the company's recent decision to reformulate Natural Light to reduce its carbs to match Miller Lite's 3.2 grams per bottle. Stokes says this will give Anheuser-Busch a low-carb beer "at the very opposite end of the price and image spectrum" of Michelob Ultra. It's a good way to attack Miller Lite without cannibalizing sales of Michelob Ultra.

In summary, Anheuser-Busch's 2003 showed us that even well-managed companies will hit some potholes along the way. The best, however, are built well enough to prevent serious problems.

Do you think management's steering the right course for Anheuser-Busch? Let us know on the Anheuser-Busch discussion board.

Rex Moore prefers Bud and owns shares in Anheuser-Busch.

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

TD AMERITRADE
more info
ShareBuilder
more info
Power E*Trade

more info
Scottrade
more info
Fool Disclosure

DocumentId: 505435, ~/Articles/ArticleHandler.aspx, 12/2/2009 9:53:17 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

The Must-Read Story on Fool.com
Fool Blog: Investment Classics for Short Attention Spans

Related Tickers

12/2/2009 9:36 AM
BUD $52.97 Up +0.72 +1.38%
Anheuser-Busch InB… CAPS Rating: ***

Community: Investing Wiki

Term Of The Hour

Series 7: Series 7 is a test given by the non-governmental Financial Industry Regulatory Authority (FINRA); a person passing the test is deemed ready and able to solicit, buy, and sell securities products. The Series 7 is usually taken by beginning stockbrokers-to-be who are sponsored by financial firms.

Want to learn more or edit this definition?
Click here to read more!